Viking Therapeutics (VKTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the ...

Viking is developing VK2735, its dual GIP/GLP-1 receptor agonist, in injectable form -- like current marketed weight treatments -- and it's also working on an oral version. The former is involved in a ...

Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates in phase 2 and phase ...

A metal detectorist convicted of stealing part of a Viking hoard valued at £3m is back in jail after not paying back his ...

Viking Therapeutics (NASDAQ: VKTX) is set to give its latest quarterly earnings report on Wednesday, 2025-10-22. Here's what ...

The Augustana offense flexed once more on Saturday afternoon, knocking off Southwest Minnesota State 57-29 on Mattke Field at ...

On 1795, Pinckney's Treaty with Spain settled Florida's northern boundary and gave navigation rights on the Mississippi River ...

Keep Saquon Barkley mired in his seasonlong slump and the Vikings beat the Eagles at home. That’s how all of us saw Sunday’s ...

Viking on Thursday reported a third-quarter loss per share of $0.81, compared to the expected loss of $0.7 per share. ・Morgan ...

The Minnesota Vikings under coach Kevin O'Connell have focused and prided themselves on situational mastery from third downs ...